bifeprunox has been researched along with ro 63-0563 in 1 studies
| Studies (bifeprunox) | Trials (bifeprunox) | Recent Studies (post-2010) (bifeprunox) | Studies (ro 63-0563) | Trials (ro 63-0563) | Recent Studies (post-2010) (ro 63-0563) |
|---|---|---|---|---|---|
| 30 | 1 | 12 | 12 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christoffersen, CT; Jensen, AA; Kehler, J; Krogsgaard-Larsen, N; Schrøder, TJ | 1 |
1 other study(ies) available for bifeprunox and ro 63-0563
| Article | Year |
|---|---|
Novel aza-analogous ergoline derived scaffolds as potent serotonin 5-HT₆ and dopamine D₂ receptor ligands.
Topics: Ergolines; Humans; Ligands; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists | 2014 |